Vitamin Shoppe, Inc (NYSE:VSI) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday.

According to Zacks, “Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products. It primarily sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids. Based in North Bergen, New Jersey, the company is recognized as an innovator in providing product information, associate training, and customer education. Information is available to consumers through unprecedented outlets including television, radio, friends, family, health practitioners, and the internet. It offers consumers the opportunity to take charge of their own health and wellness requirements, and supplement where necessary. At each store location, consumers can find a comprehensive Learning Center which offers free access to vital information about key health concerns and products. The Vitamin Shoppe is a strong supporter of health and wellness campaigns including Life Supplemented sponsored by the Council for Responsible Nutrition. “

VSI has been the topic of a number of other research reports. BidaskClub downgraded Vitamin Shoppe from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. Morgan Stanley set a $8.00 target price on Vitamin Shoppe and gave the stock a “hold” rating in a research report on Thursday, August 10th. Goldman Sachs Group, Inc. (The) reissued a “sell” rating and issued a $6.00 price objective (down from $13.00) on shares of Vitamin Shoppe in a research report on Thursday, August 10th. Deutsche Bank AG reissued a “hold” rating and issued a $7.00 price objective (down from $14.00) on shares of Vitamin Shoppe in a research report on Thursday, August 10th. Finally, Barclays PLC reduced their price objective on Vitamin Shoppe from $13.00 to $6.00 and set an “equal weight” rating for the company in a research report on Thursday, August 10th. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and one has issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $9.92.

Shares of Vitamin Shoppe (NYSE VSI) opened at 5.10 on Wednesday. Vitamin Shoppe has a one year low of $4.95 and a one year high of $27.83. The stock’s 50 day moving average is $5.35 and its 200-day moving average is $10.21. The stock’s market capitalization is $118.44 million.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings data on Wednesday, August 9th. The specialty retailer reported $0.23 EPS for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.16). The firm had revenue of $304.84 million for the quarter, compared to analysts’ expectations of $314.74 million. Vitamin Shoppe had a negative net margin of 11.98% and a positive return on equity of 8.33%. Vitamin Shoppe’s quarterly revenue was down 8.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.55 earnings per share. On average, equities research analysts expect that Vitamin Shoppe will post $0.80 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Vitamin Shoppe, Inc (VSI) Lifted to “Hold” at Zacks Investment Research” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2017/10/25/vitamin-shoppe-inc-vsi-lifted-to-hold-at-zacks-investment-research.html.

In related news, Director John D. Bowlin acquired 40,000 shares of the company’s stock in a transaction on Friday, August 25th. The stock was purchased at an average cost of $5.50 per share, for a total transaction of $220,000.00. Following the completion of the purchase, the director now directly owns 56,028 shares of the company’s stock, valued at approximately $308,154. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 1.07% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in VSI. Dynamic Technology Lab Private Ltd increased its stake in shares of Vitamin Shoppe by 72.7% in the second quarter. Dynamic Technology Lab Private Ltd now owns 17,761 shares of the specialty retailer’s stock valued at $207,000 after buying an additional 7,478 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Vitamin Shoppe by 88.5% in the second quarter. Goldman Sachs Group Inc. now owns 124,077 shares of the specialty retailer’s stock valued at $1,445,000 after buying an additional 58,243 shares in the last quarter. Wolverine Trading LLC acquired a new stake in shares of Vitamin Shoppe in the second quarter valued at $131,000. Voya Investment Management LLC increased its stake in shares of Vitamin Shoppe by 7.5% in the second quarter. Voya Investment Management LLC now owns 34,810 shares of the specialty retailer’s stock valued at $406,000 after buying an additional 2,414 shares in the last quarter. Finally, Parametric Portfolio Associates LLC increased its stake in shares of Vitamin Shoppe by 71.2% in the second quarter. Parametric Portfolio Associates LLC now owns 128,156 shares of the specialty retailer’s stock valued at $1,493,000 after buying an additional 53,279 shares in the last quarter. Hedge funds and other institutional investors own 98.39% of the company’s stock.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Get a free copy of the Zacks research report on Vitamin Shoppe (VSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.